Invention Grant
- Patent Title: Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab
-
Application No.: US15225428Application Date: 2016-08-01
-
Publication No.: US10765741B2Publication Date: 2020-09-08
- Inventor: Svetomir N. Markovic , Wendy K. Nevala
- Applicant: Mayo Foundation for Medical Education and Research
- Applicant Address: US MN Rochester
- Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee Address: US MN Rochester
- Agency: Myers Bigel, P.A.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K47/64 ; C07K16/22 ; A61K31/337 ; A61K9/51 ; A61K9/00 ; A61K31/282 ; C07K16/28 ; A61K38/38 ; A61K47/69 ; A61K47/68 ; C07K16/30 ; A61K9/16
Abstract:
This document provides methods and materials related to treating cancer (e.g., skin cancer). For example, methods and materials relating to the use of a composition containing albumin-containing nanoparticle/antibody complexes (e.g., Abraxane®/anti-VEGF polypeptide antibody complexes) to treat cancer (e.g., skin cancer) are provided.
Public/Granted literature
- US20170106087A1 Cancer Treatments Public/Granted day:2017-04-20
Information query
